Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Guizhou Xinbang Pharmaceutical Co., Ltd.
—
Guizhou Xinbang Pharmaceutical Co., Ltd. is led by CEO Lingzhong Kong, employs 4,702 people, headquartered in Guiyang, CN, publicly traded since 2010.
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) stock trades at $2.85 with a market capitalization of $5.99B. The stock is valued at a price-to-earnings (P/E) ratio of 51.33, price-to-book of 0.87, price-to-sales of 1.14. Over the past 52 weeks the stock has ranged between $2.54 and $4.15, and currently trades 31.3% below its 52-week high. It pays a dividend yielding 2.88%.
On profitability, Guizhou Xinbang Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 2.66%, an operating margin of 6.00%, a net profit margin of 2.15%.
Official website: www.xinbang.com
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) — frequently asked questions
What is Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) stock price today?
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) is currently trading at $2.85, down 1.72% today.
What is 002390.SZ P/E ratio?
Guizhou Xinbang Pharmaceutical Co., Ltd.'s P/E ratio is 51.33. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 002390.SZ return on equity (ROE)?
Guizhou Xinbang Pharmaceutical Co., Ltd.'s return on equity (ROE) is 2.66%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Guizhou Xinbang Pharmaceutical Co., Ltd.'s market cap?
Guizhou Xinbang Pharmaceutical Co., Ltd. has a market capitalization of $5.99B.
Does 002390.SZ pay a dividend?
Yes. Guizhou Xinbang Pharmaceutical Co., Ltd. currently yields 2.88%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 002390.SZ carry?
Guizhou Xinbang Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.06. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002390.SZ's profit margin?
Guizhou Xinbang Pharmaceutical Co., Ltd. reports a net profit margin of 2.15% — the share of revenue left after every cost, including tax and interest.
What sector is 002390.SZ in?
Guizhou Xinbang Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002390.SZ listed on?
Guizhou Xinbang Pharmaceutical Co., Ltd. trades on SHZ under the ticker 002390.SZ.
What is 002390.SZ's 52-week range?
Over the last year Guizhou Xinbang Pharmaceutical Co., Ltd. has traded between $2.54 and $4.15.
Related — Stocks
Popular Stocks
Screens 002390.SZ currently matches
On the figures above, Guizhou Xinbang Pharmaceutical Co., Ltd. passes the filters for 13 of our ready-made screens, among them Low PB Stocks, Dividend Stocks, Low Debt Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.